… ts negative effect on conduction time, caution must be exercised if it is given to patients with first-degree heart block.
• May mask the symptoms of hypoglycaemia, in particular, tachycardia.
• May mask the signs of thyrotoxicosis.
• Will reduce heart rate as a result of its pharmacological action. In the rare instances when a treated patient develops symptoms which may be attributable to a slow heart rate and the pulse rate …
Identical in all 5 labels. Surrounding text shown from Aurobindo Pharma - Milpharm Ltd..
… ould further increase the risk of severe hypoglycaemia when used concurrently with sulfonylureas. Diabetic patients should be advised to carefully monitor blood glucose levels. (see Section 4.5).
• may mask the cardiovascular signs of thyrotoxicosis.
• will reduce heart rate, as a result of its pharmacological action. In the rare instances when a treated patient develops symptoms which may be attributable to a slow heart rate, the dose may be r …
Identical in both labels. Surrounding text shown from Wockhardt UK Ltd.
… atenolol's negative effect on conduction time, caution must be exercised if it is given to patients with first degree heart block.
May mask the symptoms of hypoglycaemia, in particular tachycardia
The signs of thyrotoxicosis may be masked by atenolol treatment.
May cause a hypersensitivity reaction including angioedema and urticaria.
Will reduce heart rate as a result of its pharmacological action. In the rare instances where a treated patient develops s …
… s could further increase the risk of severe hypoglycaemia when used concurrently with sulfonylureas. Diabetic patients should be advised to carefully monitor blood glucose levels. (see Section 4.5)
Thyrotoxicosis: Beta-blockade may mask cardiovascular signs of thyrotoxicosis.
Allergies: Atenolol may increase both the sensitivity towards allergens and the seriousness of anaphylactic reactions. Atenolol may reduce the efficacy of the usual dose of adrenaline (epinephrine) …
… s could further increase the risk of severe hypoglycaemia when used concurrently with sulfonylureas. Diabetic patients should be advised to carefully monitor blood glucose levels. (see Section 4.5).• May mask the signs of thyrotoxicosis• Will reduce heart rate as a result of its pharmacological action. In the rare instances when a treated patient develops symptoms which may be attributable to a slow heart rate and the pulse rate dro …